Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
Get the latest Releaf Cannabis Clinic news, updates, and announcements. Stay informed about our services, events, and medical cannabis expertise.
Along with adapting to a whole new treatment option, patients just starting with medical cannabis treatment can sometimes find themselves feeling a little inundated by the terminology, acronyms, and jargon that accompany their treatment plan. One of the key terms for new patients to get their head around is MDT: Multidisciplinary Team.
We all suffer from bloating, cramping, and constipation from time to time, but certain conditions and medications can make these symptoms particularly problematic.
Explore the potential of medical cannabis in 2025 as an alternative healthcare option in the UK. Learn how Releaf helps patients address health concerns like anxiety, chronic pain, and more with personalised, patient-centred treatment plans. Discover the benefits, conditions eligible for treatment, and how to take the first step toward a healthier you this New Year.
While most people look for alternative treatment options because conventional medicines haven’t met their needs, an increase in prescription drug shortages in the UK is leaving more patients without access to effective medications.
With UK medical cannabis going nothing short of viral in the past 12 months or so (and patient numbers climbing at an exponential rate), the need for clear, concise information regarding medical cannabis accessories has never been more obvious.
This year, we’ve taken a leaf from Spotify’s book and put together a collection of our favourite moments during 2024. As the year draws to a close, here we reflect on our milestones, growth, and most importantly, the transformative difference we’re making for patients.
Releaf has been at the forefront of the UK medical cannabis sector throughout 2024, garnering widespread media attention for its innovative patient-first approach and groundbreaking initiatives. From leading the conversation around accessibility to driving awareness of medical cannabis treatment options, Releaf has consistently made headlines, shaping the narrative of this rapidly evolving industry. With notable features in national publications and influential platforms, the spotlight on Releaf reflects its commitment to transforming lives and redefining the future of medical cannabis care in the UK.
With the holiday season less than two weeks away, we want to make sure each and every Releaf patient is well-prepared for the slight changes to our normal operating schedule - and the minor adjustments to medication delivery during this year's festive period.
The holiday season is fast approaching, and with it, the yearly yearning to pack your bags, hit the road and hopefully escape the winter blues.
The days are drawing in and Christmas is right around the corner. Many of us will be working our way down Christmas lists, trying to find the perfect presents for our loved ones.
The winter months can be tough for all of us, but especially those living with chronic health conditions who may see their symptoms worsen with the lower temperatures.
More people throughout the UK are looking for alternative options to manage long-term health conditions.
Medical cannabis has demonstrated therapeutic potential across a wide range of conditions and symptoms, including muscle spasms.
Last year, our representative research found 68% of UK adults would consider medical cannabis treatment if their doctor recommended it, but around 1 in 4 said they would be apprehensive about, and perhaps discouraged by, the costs involved.
Challenges like record-high waiting lists and the rising prevalence of chronic conditions are prompting interest in alternative treatment options, including medical cannabis.
Medical cannabis treatment is quite an individual process, which means there is no one-size-fits-all answer to the question of how often you should see your doctor. Each and every patient we see here at Releaf responds at least slightly differently to their treatment protocol. This is the main reason our world-class clinical team takes such a personalised approach to each patient's care and why it is essential that all patients see their doctor regularly.
Being kind can mean a lot of things to a lot of people. It can mean taking out your elderly neighbour’s bins every week or going out of your way to make a loved one - or even a stranger - feel appreciated. But it can also mean taking care of yourself by making considered choices for a healthier and more well-rounded life.
Medical cannabis flower is the most commonly prescribed cannabis-based medication here in the UK. But unlike most treatment options, both traditional and alternative, it is not delivered to patients in a fully 'ready-to-administer' form.
As October draws to a close, so does ADHD Awareness Month - but, its sentiment stands strong year round. In fact, just last year, a study of over 7 million people showed ADHD diagnosis rates increased 20-fold between 2000 and 2018 in the UK, and a 50-fold increase was noted in prescriptions for ADHD medications amongst men aged between 18 and 29.
Friday the 1st of November 2024 marks six years of medical cannabis in the UK. For the last six years, (since November 1, 2018) specialist doctors like those working at Releaf have been able to prescribe medical cannabis flower, and cannabis oil, to eligible patients when traditional treatments have proved ineffective.
Medical cannabis flower is the most prescribed CBPM in the UK, and it is intended to be administered through a dry herb vaporiser.
Medical cannabis was legalised almost 6 years ago as an alternative treatment option for a large volume of health conditions when conventional approaches have proved ineffective.
Medical cannabis has been prescribed for a wide range of conditions in the UK since the legislation of cannabis-based treatments on the 1st of November 2018. Since then, tens of thousands of patients have received a prescription for cannabis-based medicines; however, there are several conditions, including schizoaffective disorder, for which medical cannabis is not considered a suitable option. But why is this?
Today, we continue our 'New Patient' blog series in the same vein, but this time, we'll give a brief (but in-depth) overview of how medical cannabis is taken and why sublingual administration is the most commonly prescribed method.
In this article, we explore the distinction between illegal, unregulated THC vape pens and legally prescribed medical cannabis flower. Understanding the difference is crucial— especially for patients— when it comes to making informed choices about your health.
Women and people who menstruate face several unique health challenges, in addition to a higher risk of some medical conditions. Yet, women often struggle to access effective solutions for these conditions, leaving many forced to live with the burden of their symptoms.
The medicinal potential of cannabis and its derivatives has been a focus of medical research for hundreds of years. Yet, there remains a significant number of unknowns around this complex and versatile plant. With that in mind, we’re taking a closer look at some of the most significant medical cannabis research published so far in 2024.
Welcome back to our 'New Patient' blog series, where we cover all the frequently asked questions, along with treatment tips and product options for new patients interested in UK medical cannabis.
Tomorrow is World Hospice and Palliative Care Day, which falls on the second Saturday of October each year and marks a time to reflect on the importance of compassionate and effective care for those facing life-limiting and terminal illnesses.
At Releaf, we prescribe two main formulations of cannabis-based medicines to our patients - medical cannabis flower and medical cannabis oil. Most people have a fair understanding of medical cannabis flower, but medical cannabis oil is still somewhat of an enigma to many.
Yesterday (Sunday 6th October) marked World Cerebral Palsy Day, a global movement which aims to raise awareness, and ensure a future in which those with Cerebral Palsy have the same rights and opportunities as everyone else.
It may not be as well known as its fellow cannabinoids CBD and THC, but early research suggests CBG has significant potential in a range of health conditions; from easing anxiety to helping tackle antimicrobial resistance. Here’s everything you need to know.
Now that medical cannabis has been legally available in the UK for almost six years, powerful patient testimonials are hitting the press highlighting how medical cannabis has helped people manage PTSD, depression, and anxiety symptoms.
Cannabis-based medicines can be prescribed to patients in the UK for the treatment of a wide range of conditions. Among these are several neurological conditions, including multiple sclerosis, epilepsy, Parkinson’s disease and ADHD. In this article, we take a look at the causes and characteristics of these conditions and assess the evidence for the potential efficacy of medical cannabis.
One thing that almost every new patient asks us here at Releaf is: "Do I have to tell my employer that I am a medical cannabis patient?" The short answer is 'no', but there is a little more to it than that.
There’s a lot of misinformation out there when it comes to cannabis and cancer. To mark Breast Cancer Awareness Month, we want to empower patients with information about their options, and how medical cannabis can play a role as an adjunctive therapy in cancer treatment plans.
Patients in the UK have been able to access legal, regulated medical cannabis products for almost six years. Since the legalisation of medical cannabis in 2018, tens of thousands of patients have experienced the benefits of this incredible plant and its derivatives. But how do you know if medical cannabis is a good option for your health condition?
Welcome back to our 'New Patient' series, where we answer all the more frequently asked questions that prospective (and newly signed up) Releaf patients often have. In today's write-up, we will quickly explore what happens directly after you have your initial consultation with one of our world-class clinical team.
Discover how medical cannabis may help manage Alzheimer’s symptoms like anxiety and sleep issues. Learn more on World Alzheimer’s Day 2024, and explore treatment options available in the UK.
Curious as to who can prescribe medical cannabis in the UK? Well, meet Releaf’s team of specialists, from GPs to specialists n Neurology, Psychiatry, Oncology, Rheumatology and Palliative Care, our clinical team collaborate to create the best bespoke treatment plan possible, for each individual patient.
With a large proportion of Releaf patients choosing the Omura Vaporiser to "heat, not burn" their prescribed medical cannabis flower options, we thought it was about time to quickly discuss how to use the Flowerstick Home Fill System.
Right now, here in the UK, the stats surrounding the rates of cancer are pretty alarming - Did you know that one in two UK residents will develop some form of cancer during their lifetime?
Medical cannabis has become increasingly accessible and accepted in recent years. However, accessing cannabis-based products - even from legal sources - can have an impact on everyday life. From medicating in public or even the comfort of your own home to driving and employment, there are many things to consider when becoming a medical cannabis patient.
Even though medical cannabis has been a full legal treatment option here in the UK since 1 November 2018, there is still a level of stigma surrounding it. It is anything but a surprise that some patients are worried about how their decision to pursue a medical cannabis prescription may affect their relationship with their general practitioner (GP).
Menopause is an inevitability for around half the population. It’s a biological standard and a natural part of ageing that affects around 33 million people - but - that doesn’t mean it’s easy to manage. Recently, interest surrounding alternative therapies has increased, and more women are now making the switch from traditional treatments like HRT to natural alternatives like medical cannabis for menopause symptom management.
Humans have been reaping the benefits of cannabis for thousands of years, whether for its nutritional value, industrial uses, or its therapeutic potential. Yet, an almost worldwide prohibition of cannabis in recent decades has meant that education around this impressive and complex plant is lacking - even as a growing number of countries continue to re-introduce its medicinal use.
Starting any new treatment option can be slightly daunting, but this is especially true when it comes to medical cannabis. Thanks to the more than century-long campaign of cannabis prohibition and stigmatisation, there is still an undercurrent of misinformation and misunderstanding around this fascinating plant and its potential therapeutic benefits - even though it has been a legal treatment option here in the UK for almost six years.
Because they affect around one in seven people, Migraine Awareness Week is a crucial initiative to spotlight the significant impact migraines have on millions of lives worldwide. With conventional treatments not always able to provide adequate relief, medical cannabis has emerged as a promising alternative.
Starting your medical cannabis journey with Releaf ensures that you have access to some of the best medical cannabis specialists, treatment options, and patient care/support in the UK, but that doesn't mean you won't still have a few questions.
If you’ve been looking to try a new treatment option to manage your symptoms or health conditions for years and have only just found out medical cannabis is a legal option in the UK, you may be eager to find out how quickly you can start medical cannabis treatments.
Becoming a Releaf medical cannabis patient and accessing your medical cannabis consultations is easy, and the entire process can be done from the comfort of your own home.
Pain is an extremely complex symptom that can be linked to a wide range of sources and conditions. But while most people experience pain as an occasional and temporary disruption, many experience it as a more significant burden that significantly affects their quality of life. This may be due to the development of certain medical conditions which can be associated with different types of pain.
Despite medical cannabis being legal in the UK for almost six years, there is still confusion— and mixed messages—around the rights and responsibilities of patients when it comes to driving with their prescription.
We officially launched six months ago on February 1st after almost a year of hard work and preparation. We now have over 20,000 members in our community, and thought it was time to take a trip down memory lane to see how we achieved this, what we’ve learnt along the way, and what our patients have to say.
Fibromyalgia is a chronic condition which can be hard to diagnose and hard to treat. But in many patients— and supported by a growing evidence base— medical cannabis is showing promise for symptom management and improving quality of life. We take a closer look at the research and hear from those with first-hand experience.
The UK medical cannabis sector is one of the safest and most highly regulated in the world. This is thanks to the strict procedures and guidelines put in place by regulatory bodies such as the Medicines and Healthcare product Regulatory Agency (MHRA), the Quality Care Commission (CQC), and NICE (National Institute for Health and Care Excellence). These organisations ensure that the medical cannabis products available to UK patients are safe, effective, and high quality.
Conditions that affect the gastrointestinal tract - often called gastroenterological conditions - can greatly affect an individual’s health and quality of life. Yet, despite being relatively common in the Western population, effective management of these conditions and their symptoms is often elusive. However, in recent years, emerging evidence has indicated that medical cannabis may have a role to play in reducing the burden of some of the most common gastroenterological conditions.
Every August, the National Psoriasis Foundation hosts Psoriasis Action Month - a time dedicated to raising awareness around this common disease and providing advice and support to those affected. Despite affecting an estimated 125 million people worldwide, the impact of psoriasis is still not widely understood.
Medical cannabis treatment and finding the perfect combination of cultivar (or oil) and dosage sizing is, at least in some respect, an individualised process. Some patients find the level of symptom management they are hoping for straight away, but for others, it can take a little bit of experimentation to find the balance that works best for them.
Medical cannabis has recently hit the big time here in the UK. Although it's been legal for just over six years (since November 2018), the general public's understanding of this has been surprisingly lacking. That is, until now.
From Morrisons to medical cannabis clinics, CBD seems to be everywhere – but, what actually is it? For National CBD Day, we explain the A-B-Cs of CBD, from its plant-based origin to its clinical applications – here’s everything you need to know about CBD.
Cannabis is an incredibly complex plant that contains thousands of active compounds. While the most well-known compounds may be cannabinoids - and of these, CBD and THC enjoy the most coverage - another class of compounds contribute significantly to the potential benefits of this incredible plant: Terpenes.
Storing most medications correctly is essential to not only the shelf life but also the overall efficacy. This is (debatably) even more important when it comes to dried medical cannabis flower, as it is an organic product, unlike most conventional pharmaceuticals.
Welcome to a day in the life of a Medical Cannabis Clinical Director in the UK! We spoke to our very own Dr David Tang about his role and responsibilities as Releaf’s Clinical Director to lift the curtain on what happens behind the scenes in the UK’s fastest growing medical cannabis clinic in the UK.
Every patient is unique, and so are their medical needs. As a medical cannabis clinic, having a varied formulary allows us to cater to a large cohort of patients, from those with chronic pain or insomnia, to those with anxiety and depression, or MS and Parkinson’s, and offer them each unique, individualised treatment plans.
Decisions surrounding palliative care are something that almost all of us will face at some point in our lives, whether for ourselves or for someone we care deeply about. But before that time comes, it's a subject that is often avoided or at least slightly misunderstood.
We know what a difference the right vape can make, that’s why we’ve given out over £115,000 of Omura products to medical cannabis patients in the UK for free.
Every year, the 25th of July commemorates National Schizophrenia Awareness Day - an event established by mental health charity, Rethink Mental Health. The day aims to shine a spotlight on the everyday challenges faced by the millions of people living with schizophrenia and the stigma and discrimination that still remain around this diagnosis.
In today's write-up, we will explain all the factors that can and do affect the price of medical cannabis cultivars. Here at Releaf, we want to ensure that our patients are well-informed about their medication options, including the pricing factors.
In the last two decades, global plastic production has doubled, with 400 million tonnes of plastic waste now produced every year. As one of the only UK clinics to provide medical cannabis flower in eco-friendly packaging, Releaf is committed to finding more sustainable solutions this Plastic Free July and is taking steps towards a plastic-free future.
Medical cannabis was legalised in the UK in 2018 for patients with health conditions known to respond to cannabis-based treatments, if conventional or licensed medications have failed to meet their needs. Because one of these health conditions is Multiple Sclerosis, Releaf are joining MS-UK for a free Webinar on the 21st of August, to explain how these treatments can be safely incorporated into MS treatment plans.
One month ago, we announced our first-of-its-kind partnership with Glass Pharms® - an arrangement that aims to reduce hurdles between the prescription and receipt of medical cannabis products in the UK. One month on, we have been thrilled to see how this partnership has brought medical cannabis into the mainstream news once again.
Although our phone lines are open from 9 to 5 Monday through Friday, Releaf’s Patient Support Team work tirelessly around the clock behind the scenes, to ensure we provide the most seamless, and supportive service to medical cannabis patients in the UK.
When medical cannabis was legalised in the UK in November 2018, many understandably assumed that it would be as simple to access these medications as any other prescription medicine. Unfortunately, it soon became clear that this wouldn’t be the case.
All medications come with the possibility of interactions with other drugs/pharmaceuticals, and medical cannabis is no exception. Continuing on with our 'New Patient' series, we dig our teeth into the often-asked question: "What medications interact with medical cannabis?"
Are you a medical cannabis patient in the UK that’s unhappy with the service your current clinic provides? Discover Releaf’s seamless transition process and experience UK-grown prescribed cannabis options, extensive clinical expertise, and an innovate all-in-one patient focused platform by making one simple switch.
At Releaf, we have streamlined the triage process to ensure our patients receive the highest quality care and treatment in the shortest possible time, including prescription delivery.
Here at Releaf, we are constantly improving our processes and medical cannabis delivery service to ensure that our patients receive their prescribed medication in a timely and efficient manner, and for good reason. This isn't any old online shopping order they're waiting on. It's their medication - something that is vital to their health and wellbeing.
Medical cannabis has been legal in the UK since 2018, but the prescription of cannabis-based products for medicinal use (CBPMs) is a strictly regulated and complicated process. Here we’ll take a closer look.
With the summer holidays fast approaching, many of you will be either looking at, or looking forward to, getting away for a much-needed break. But, for those who are prescribed medical cannabis, you may be wondering what protocols are involved when travelling internationally with cannabis-based medicines - but don’t worry, we’ve got you covered!
Announced in The Sunday Times, Releaf have made history with the launch of a range of domestically, UK-grown medical cannabis cultivars. Releaf patient Chloe Durrington became the first person ever in the UK to receive prescribed medical cannabis flower that was grown here in the UK, by Glass Pharms®, just 200 miles from her home. Want to be among the first people in the UK to receive UK-grown medical cannabis on prescription? Check your eligibility here or speak to your Releaf clinician.
In November 2018, medical cannabis and cannabis-derived medicines were legalised as prescription only medicines in the UK. This means they can now be prescribed by specialist doctors to patients who have a condition that is known to respond to cannabis, if they have been unable to find success with conventional or licensed approaches.
This week is Multiple Sclerosis (MS) Awareness Week, where we shine a spotlight on this chronic disease that affects more than 130,000 people in the UK (and millions worldwide), and see how the change to UK medical cannabis laws is opening up new treatment options.
Endometriosis is estimated to affect around 10% of those with a womb between puberty and menopause, but still, effective treatments, and research into the condition itself, are severely lacking. This can, understandably, be extremely frustrating for those affected.
Earth Day (22 April) is an annual celebration of our natural environment — and more important than ever amid the global climate crisis. How can those entering the emerging medical cannabis industry ensure they adopt eco-friendly practices from the off?
We are living through what can only really be described as a health-care revolution. Cannabis, long seen by the UK 'powers that be' as nothing more than a recreational drug, now has the spotlight squarely aimed at its medicinal and therapeutic properties.
We know that starting a new healthcare treatment plan, especially one that has only recently been made available, can feel daunting. When patients first consider trying medical cannabis, many aren’t quite sure of what to expect or know who to turn to for answers to their questions.
As part of our Experts explain series, we sat down with Dr Sue Clenton, an expert Oncologist and Specialist Consultant at Releaf, to speak about medical cannabis treatments and chronic pain.
In the UK, General Practitioners sit on the forefront and frontline of healthcare, and they are typically a person's first port of call when something arises with their health. But, unfortunately, in the UK, GPs cannot issue a prescription for cannabis-based treatments to a patient who has never received them before. They can, however, assist in shared care agreements, hold follow-up appointments, and issue repeat prescriptions for medical cannabis.
We want to make your first steps down the road towards better health as smooth as possible. That's why we've put together this straightforward guide to help you understand what we need to know before beginning your medical cannabis treatment.
At Releaf, we’re on a mission to make accessing medical cannabis treatments as easy as possible for those that need them, and one of the ways we’re doing this is by breaking down barriers, answering FAQs, and debunking myths. So today, we’re discussing what to expect at your first medical cannabis consultation with Releaf.
In the UK, one of the most prominent misconceptions that shrouds understanding and acceptance of medical cannabis is the idea that medical cannabis is smoked. However, contrary to widespread belief, this is not the case, and in the UK, medical cannabis will never be prescribed with this intention in mind.
Releaf offers every patient a medical cannabis card with their prescription to help ensure peace of mind when administering their medicine in public. Here’s everything you need to know about how it works.
Hello, and welcome to the first of many conversations with Releaf’s specialist doctors. This week we’re speaking to our expert Rheumatologist, Dr Hanna Gul, about the benefits medical cannabis may be able to offer to patients who are struggling with fibromyalgia.
In the UK, medical cannabis has been a legal treatment option since November 2018 (just over six years). Even so, a large proportion of the population remain unaware of how prescriptions for cannabis-based treatments are issued, and how patients buy medical cannabis in the UK.
When prospective patients start to explore the world of medical cannabis, pricing strategies or how much medical cannabis costs are often at the forefront of their minds. This is completely understandable considering that to establish whether medical cannabis may be the right option for you, you need to know if it's within your budget, and therefore, the price of medical cannabis in the UK.
The Food Standards Agency and Food Standards Scotland have updated their advice on the Acceptable Daily Intake (ADI) for cannabidiol in a move that has alarmed the CBD industry. In February 2020, the FSA published advice on CBD consumption for the first time. This guidance explained that consumers should not exceed 70mg of CBD in a 24-hour period. However, this week has seen a dramatic reduction in that number, slashed to 10mg per day for healthy adults, highlighting potential long-term side effects.
The wait is over, you finally have a legal medical cannabis prescription. For some, this will have been a long wait, for others who have only just become aware of the benefits of medical cannabis, it is the start of a new journey. At Releaf we want you to feel confident about being a legal medical cannabis patient which is why we want to take a moment to talk about cannabis stigma.
This November marks the third year of celebrating Medical Cannabis Awareness Week - a whole week dedicated to highlighting the successes of the medical cannabis industry but also provides an opportunity to bring together all sectors for reflection and discussions. Drug Science, leaders of the T21 medical cannabis patient study are hosting The Patient Conference with The Medcan Family Foundation on November 3rd at Conway Hall in London. Tickets are available here.
The 1st of November 2023 is an important day for many in the medical cannabis community, because it marks five years of its legalisation in the UK. But, what you may not have known is that November the 1st is also the day dedicated to raising awareness of stress – a condition medical cannabis has shown potential in alleviating.
To get a deeper understanding of the medical cannabis industry in the UK, we’ve decided to investigate some of the key statistics that shape the cannabis landscape as we know it. The Releaf Medical Cannabis Statistic Series examined the impact of medical cannabis across three crucial domains: the economy, health, and society.
Dr Charlie Easmon is a highly acclaimed international health expert, who has ventured through over 75 countries, observing and evaluating local medical facilities for the last four decades.
Here at Releaf, we are thrilled to announce the release of our first market research report that investigates the awareness and prevalence of medical cannabis in the UK, and analyses the public perceptions and societal stigmas that surround this powerful plant.
Here at Releaf we are delighted to announce that we have joined the ranks of one of the UK's leading membership organisations for the cannabis industry: The Cannabis Industry Council (CIC).
Creator of the world famous Big Buddha Cheese, Milo Yung passed away in his sleep at age 51 on April 27th 2023 leaving behind a life of work celebrating the cannabis plant.
